Change search
ReferencesLink to record
Permanent link

Direct link
SOX2 expression is regulated by BRAF and contributes to poor patient prognosis in colorectal cancer
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Umeå University, Faculty of Medicine, Department of Medical Biosciences, Pathology.
Show others and affiliations
2014 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 9, no 7, e101957- p.Article in journal (Refereed) Published
Abstract [en]

Sporadic colorectal cancer (CRC) is a common malignancy and also one of the main causes of cancer deaths worldwide. Aberrant expression of the transcription factor SOX2 has recently been observed in several cancer types, but its role in CRC has not been fully elucidated. Here we studied the expression of SOX2 in 441 CRC patients by immunohistochemistry and related the expression to clinicopathological and molecular variables and patient prognosis. SOX2 was expressed in 11% of the tumors and was significantly associated to BRAF(V600E) mutation, but not to KRAS mutations (codon 12 and 13). SOX2 positivity was correlated to poor patient survival, especially in BRAF(V600E) mutated cases. In vitro studies showed that cells expressing the constitutively active BRAF(V600E) had increased SOX2 expression, a finding not found in cells expressing KRAS(G12V). Furthermore, blocking downstream BRAF signalling using a MEK-inhibitor resulted in a decreased expression of SOX2. Since SOX2 overexpression has been correlated to increased migration and invasion, we investigated the SOX2 expression in human CRC liver metastasis and found that a SOX2 positive primary CRC also had SOX2 expression in corresponding liver metastases. Finally we found that cells overexpressing SOX2 in vitro showed enhanced expression of FGFR1, which has been reported to correlate with liver metastasis in CRC. Our novel findings suggest that SOX2 expression is partly regulated by BRAF signalling, and an increased SOX2 expression may promote CRC metastasis and mediate a poor patient prognosis.

Place, publisher, year, edition, pages
Public library of science , 2014. Vol. 9, no 7, e101957- p.
Keyword [en]
island methylator phenotype; transcription factor sox2; dna copy number; gene-expression; microsatellite instability; v600e mutation; lung-cancer; stem-cells; carcinoma; growth
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-91747DOI: 10.1371/journal.pone.0101957ISI: 000338763800054OAI: diva2:739074
Available from: 2014-08-20 Created: 2014-08-15 Last updated: 2015-03-24Bibliographically approved

Open Access in DiVA

fulltext(424 kB)104 downloads
File information
File name FULLTEXT01.pdfFile size 424 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Lundberg, Ida VLöfgren Burström, AnnaEdin, SofiaEklöf, VincyÖberg, ÅkeStenling, RogerPalmqvist, RichardWikberg, Maria L
By organisation
In the same journal
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 104 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 148 hits
ReferencesLink to record
Permanent link

Direct link